Recently, a number of studies showed that the over-expression of P-gp appears to be closely associated with the nuclear localization of Y-box binding protein 1(YB-1) in various solid tumors such as breast cancer, ovarian cancer, prostate cancer, and osteosarcoma [21,22,23]. This evidence concerns the gene PGP and ovarian carcinoma.